Anti-GalNAc-GD1a Monoclonal Antibody (2A3D2)1vial

4-Nitrobenzenesulfonic Acid>98.0%(HPLC)(T)25g

methyl 3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylate hydrochloride, 95.0%, 250mg

2,3,5,6-Tetrafluoro-4-methoxybenzenesulfonylchloride, 95%, 1g

2-Phenyl-1-(pyridin-4-yl)ethan-1-one, 95+%, 100mg

6-Bromo-3-(trifluoromethoxy)pyridin-2-amine, 97%, 1g

(R)-2,3-Diaminopropanoic acid, 95.0%, 5g

5-[2-(phenylthio)ethyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

2-Fluoro-1-iodo-3,4-dimethoxybenzene, 98%, 1g

2-Chloro-4-ethynylpyridine, 95.0%, 25g

4-Oxotetrahydrofuran-3-carbonitrile, 95.0%, 250mg

2,3-Dihydro-benzofuran-7-sulfonic acid amide, 95.0%, 1g

(3-Amino-2-methylphenyl)methanol, 97.0%, 50g